The study examined Day 0 lymphopenia—defined as an absolute lymphocyte count (ALC) below 0.9 cells/µL—and severe lymphopenia (ALC below 0.5 cells/µL). Both were associated with higher mortality and slower recovery. Persistent lymphopenia by Day 5 was linked to increased mortality and secondary infections, while both persistent and newly developed lymphopenia were associated with...

Dr. Shakti Singh from the Division of Infectious Diseases has been awarded the prestigious five-year K01 Grant for their innovative research on the deadly fungal pathogen Candida auris. This five year grant grant, provided by the National Institutes of Health (NIH), supports Dr. Singh’s cutting-edge work, which aims to unravel the complex mechanisms of C. auris virulence and explore new vaccine strategies.

Dr. Nicolas Millet, Postdoctoral fellow in the Swidergall lab, won a young investigator poster award at ImmunologyLA 2024, an annual forum designed to foster collaboration between immunologists in the Los Angeles area. Dr. Millet presented his work on IL-22-mediated epithelial remodeling and antifungal immunity. Dr. Millet’s work is funded by Dr. Swidergall’s NIH grant R01DE031382.

TLI Investigator Ashraf Ibrahim, PhD, has been selected by the Medical Mycology Society of the Americas (MMSA) to receive the 2024 Billy H. Cooper Award for his continuous outstanding achievement in clinical mycology, which is the diagnosis, prevention, and treatment of patients with fungal infections. TLI celebrates and congratulates Dr Ibrahim for receiving this high honor.

Loren Miller, MD, MPH was honored with a 2024 Top Ten Clinical Research Achievement Award by the Clinical Research Forum (CR Forum) at a ceremony in Las Vegas, Nevada on April 2, 2024. Dr. Miller Chief of Infectious Diseases at Harbor-UCLA Medical Center, an Investigator at The Lundquist Institute for Biomedical Innovation at Harbor-UCLA, and a Professor of Medicine at the David Geffen School of Medicine at UCLA.